SageView Advisory Group LLC Buys Shares of 12,175 Haleon plc (NYSE:HLN)

SageView Advisory Group LLC bought a new stake in shares of Haleon plc (NYSE:HLN) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 12,175 shares of the company’s stock, valued at approximately $100,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Wellington Management Group LLP lifted its stake in Haleon by 164.6% during the 4th quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock valued at $111,454,000 after acquiring an additional 8,423,475 shares during the period. Goldman Sachs Group Inc. lifted its stake in Haleon by 19.1% during the 4th quarter. Goldman Sachs Group Inc. now owns 4,813,997 shares of the company’s stock valued at $39,619,000 after acquiring an additional 772,829 shares during the period. Syon Capital LLC lifted its stake in Haleon by 31.4% during the 4th quarter. Syon Capital LLC now owns 67,711 shares of the company’s stock valued at $557,000 after acquiring an additional 16,175 shares during the period. Clear Street Markets LLC lifted its stake in shares of Haleon by 13,646.0% in the 4th quarter. Clear Street Markets LLC now owns 13,746 shares of the company’s stock worth $113,000 after purchasing an additional 13,646 shares during the period. Finally, Personal CFO Solutions LLC lifted its stake in shares of Haleon by 17.8% in the 4th quarter. Personal CFO Solutions LLC now owns 20,600 shares of the company’s stock worth $170,000 after purchasing an additional 3,115 shares during the period. Institutional investors own 6.67% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. HSBC assumed coverage on shares of Haleon in a research note on Wednesday, April 17th. They issued a “buy” rating on the stock. Berenberg Bank assumed coverage on shares of Haleon in a research note on Wednesday, June 5th. They issued a “buy” rating on the stock. Finally, Argus reiterated a “buy” rating on shares of Haleon in a research note on Tuesday, March 26th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy”.

Haleon Price Performance

NYSE HLN opened at $8.58 on Friday. Haleon plc has a 12 month low of $7.70 and a 12 month high of $8.96. The stock has a market cap of $39.18 billion, a price-to-earnings ratio of 28.60, a PEG ratio of 2.25 and a beta of 0.26. The company’s 50 day moving average is $8.38 and its two-hundred day moving average is $8.33. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.53.

Haleon (NYSE:HLN) last released its earnings results on Wednesday, May 1st. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.01. Haleon had a net margin of 9.68% and a return on equity of 13.17%. The company had revenue of $3.70 billion for the quarter, compared to analysts’ expectations of $3.71 billion. As a group, research analysts anticipate that Haleon plc will post 0.46 earnings per share for the current year.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.